| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 38 | 2020 | 147 | 8.360 |
Why?
|
| Inflammation | 25 | 2019 | 508 | 4.920 |
Why?
|
| Sirtuin 1 | 13 | 2020 | 37 | 4.100 |
Why?
|
| Monocytes | 15 | 2019 | 119 | 3.360 |
Why?
|
| Endotoxins | 14 | 2016 | 37 | 3.150 |
Why?
|
| Immune Tolerance | 16 | 2019 | 67 | 3.110 |
Why?
|
| Epigenesis, Genetic | 10 | 2019 | 98 | 2.960 |
Why?
|
| Lipopolysaccharides | 19 | 2019 | 107 | 2.500 |
Why?
|
| Gene Silencing | 8 | 2011 | 49 | 2.460 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2018 | 200 | 2.430 |
Why?
|
| Immunity, Innate | 7 | 2019 | 64 | 2.340 |
Why?
|
| Lung Injury | 8 | 2018 | 64 | 2.210 |
Why?
|
| Transcription Factor RelB | 11 | 2014 | 25 | 2.150 |
Why?
|
| Energy Metabolism | 7 | 2019 | 139 | 2.100 |
Why?
|
| Gene Expression Regulation | 16 | 2017 | 481 | 2.050 |
Why?
|
| Sirtuins | 5 | 2018 | 19 | 1.910 |
Why?
|
| Contusions | 7 | 2018 | 41 | 1.850 |
Why?
|
| MicroRNAs | 12 | 2019 | 173 | 1.850 |
Why?
|
| Mice | 36 | 2020 | 2372 | 1.680 |
Why?
|
| Transcription, Genetic | 8 | 2011 | 136 | 1.600 |
Why?
|
| Animals | 47 | 2020 | 7302 | 1.450 |
Why?
|
| Myeloid Cells | 9 | 2019 | 35 | 1.380 |
Why?
|
| Leukocytes | 10 | 2017 | 52 | 1.350 |
Why?
|
| Promoter Regions, Genetic | 10 | 2016 | 212 | 1.270 |
Why?
|
| Histones | 9 | 2017 | 49 | 1.120 |
Why?
|
| Mice, Inbred C57BL | 15 | 2020 | 711 | 1.070 |
Why?
|
| Homeostasis | 6 | 2018 | 127 | 1.060 |
Why?
|
| Toll-Like Receptor 4 | 9 | 2013 | 41 | 1.050 |
Why?
|
| Heterochromatin | 5 | 2011 | 11 | 1.040 |
Why?
|
| Disease Models, Animal | 20 | 2020 | 981 | 1.020 |
Why?
|
| Glucose | 3 | 2018 | 164 | 1.000 |
Why?
|
| Signal Transduction | 9 | 2019 | 666 | 0.850 |
Why?
|
| Interleukin-6 | 9 | 2018 | 225 | 0.840 |
Why?
|
| Cell Line | 14 | 2016 | 450 | 0.820 |
Why?
|
| Humans | 49 | 2019 | 29213 | 0.820 |
Why?
|
| Histocompatibility Antigens | 3 | 2009 | 10 | 0.790 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2009 | 21 | 0.780 |
Why?
|
| Drug Resistance | 2 | 2011 | 36 | 0.740 |
Why?
|
| Oxidative Stress | 3 | 2019 | 223 | 0.740 |
Why?
|
| Cell Nucleus | 3 | 2018 | 105 | 0.740 |
Why?
|
| Mitochondria | 3 | 2018 | 174 | 0.740 |
Why?
|
| Interleukin-1beta | 5 | 2011 | 41 | 0.740 |
Why?
|
| Cysteine | 2 | 2019 | 131 | 0.730 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 14 | 0.690 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2018 | 13 | 0.660 |
Why?
|
| Protein Biosynthesis | 6 | 2015 | 46 | 0.650 |
Why?
|
| Macrophages | 6 | 2017 | 188 | 0.620 |
Why?
|
| Antioxidants | 1 | 2018 | 114 | 0.620 |
Why?
|
| NFI Transcription Factors | 5 | 2017 | 12 | 0.610 |
Why?
|
| Lung | 5 | 2018 | 233 | 0.610 |
Why?
|
| Chemokine CXCL1 | 5 | 2012 | 16 | 0.590 |
Why?
|
| Mice, Knockout | 12 | 2019 | 425 | 0.580 |
Why?
|
| DNA Methylation | 7 | 2017 | 130 | 0.580 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 4 | 0.560 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 5 | 0.560 |
Why?
|
| Immunity | 2 | 2017 | 20 | 0.530 |
Why?
|
| I-kappa B Proteins | 3 | 2011 | 10 | 0.530 |
Why?
|
| RNA, Messenger | 7 | 2016 | 514 | 0.520 |
Why?
|
| Platelet Adhesiveness | 3 | 2015 | 13 | 0.520 |
Why?
|
| Sirtuin 3 | 1 | 2014 | 3 | 0.510 |
Why?
|
| Sirtuin 2 | 4 | 2019 | 10 | 0.510 |
Why?
|
| Phenotype | 3 | 2017 | 629 | 0.510 |
Why?
|
| Male | 31 | 2020 | 17872 | 0.510 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 4 | 2019 | 4 | 0.500 |
Why?
|
| Complement Activation | 1 | 2014 | 10 | 0.490 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2012 | 13 | 0.480 |
Why?
|
| Transcription Factor RelA | 7 | 2019 | 22 | 0.460 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 312 | 0.420 |
Why?
|
| HMGB1 Protein | 2 | 2009 | 5 | 0.420 |
Why?
|
| Glycolysis | 4 | 2018 | 19 | 0.420 |
Why?
|
| Myelopoiesis | 1 | 2011 | 2 | 0.410 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2009 | 5 | 0.410 |
Why?
|
| Fatty Acids | 1 | 2012 | 93 | 0.410 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 1017 | 0.400 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2018 | 67 | 0.400 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 95 | 0.390 |
Why?
|
| Adiponectin | 1 | 2011 | 103 | 0.390 |
Why?
|
| Interleukin-10 | 4 | 2019 | 30 | 0.390 |
Why?
|
| Obesity | 5 | 2019 | 1068 | 0.390 |
Why?
|
| Lung Diseases | 2 | 2009 | 45 | 0.390 |
Why?
|
| Curcumin | 1 | 2010 | 7 | 0.380 |
Why?
|
| Chemokine CXCL2 | 2 | 2011 | 9 | 0.380 |
Why?
|
| Membrane Glycoproteins | 4 | 2014 | 97 | 0.370 |
Why?
|
| RNA-Binding Proteins | 5 | 2015 | 68 | 0.370 |
Why?
|
| Nucleosomes | 1 | 2009 | 3 | 0.370 |
Why?
|
| Cell Differentiation | 8 | 2017 | 436 | 0.360 |
Why?
|
| Cells, Cultured | 5 | 2018 | 800 | 0.360 |
Why?
|
| Peroxidase | 1 | 2009 | 33 | 0.350 |
Why?
|
| NAD | 3 | 2016 | 25 | 0.340 |
Why?
|
| Calgranulin B | 2 | 2019 | 4 | 0.340 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 13 | 0.330 |
Why?
|
| Mice, Inbred BALB C | 10 | 2018 | 160 | 0.330 |
Why?
|
| Protein Binding | 5 | 2016 | 199 | 0.320 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 152 | 0.320 |
Why?
|
| Transfection | 5 | 2016 | 192 | 0.310 |
Why?
|
| Adenosine Triphosphate | 2 | 2019 | 52 | 0.310 |
Why?
|
| Interleukin-1 | 5 | 2006 | 33 | 0.310 |
Why?
|
| Blotting, Western | 4 | 2020 | 281 | 0.300 |
Why?
|
| Cytokines | 5 | 2017 | 243 | 0.300 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2007 | 11 | 0.300 |
Why?
|
| Shock, Septic | 2 | 2018 | 28 | 0.290 |
Why?
|
| Metabolome | 2 | 2019 | 31 | 0.290 |
Why?
|
| NF-kappa B | 5 | 2017 | 75 | 0.290 |
Why?
|
| Spleen | 2 | 2014 | 82 | 0.240 |
Why?
|
| Transcription Factors | 2 | 2017 | 172 | 0.240 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 32 | 0.240 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 73 | 0.230 |
Why?
|
| Cell Adhesion | 3 | 2017 | 103 | 0.230 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 72 | 0.230 |
Why?
|
| Aging | 3 | 2015 | 881 | 0.230 |
Why?
|
| Adaptation, Biological | 1 | 2003 | 8 | 0.230 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 50 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 71 | 0.220 |
Why?
|
| Phosphorylation | 4 | 2016 | 225 | 0.210 |
Why?
|
| Protein Stability | 3 | 2013 | 26 | 0.210 |
Why?
|
| Neutrophils | 4 | 2012 | 102 | 0.210 |
Why?
|
| Inflammation Mediators | 3 | 2013 | 101 | 0.200 |
Why?
|
| Microcirculation | 2 | 2011 | 61 | 0.200 |
Why?
|
| Blood-Brain Barrier | 2 | 2011 | 42 | 0.200 |
Why?
|
| Immunomodulation | 3 | 2017 | 30 | 0.190 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2017 | 41 | 0.190 |
Why?
|
| Microvessels | 2 | 2017 | 23 | 0.190 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 22 | 0.190 |
Why?
|
| CpG Islands | 4 | 2016 | 44 | 0.180 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 49 | 0.180 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2012 | 25 | 0.180 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 250 | 0.180 |
Why?
|
| Carbohydrate Metabolism | 1 | 2019 | 13 | 0.170 |
Why?
|
| Nucleotides | 1 | 2019 | 16 | 0.170 |
Why?
|
| Carnitine | 1 | 2019 | 10 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2019 | 53 | 0.170 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 60 | 0.170 |
Why?
|
| RNA Interference | 2 | 2009 | 76 | 0.170 |
Why?
|
| Amino Acids | 1 | 2019 | 41 | 0.170 |
Why?
|
| Models, Biological | 4 | 2016 | 373 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2017 | 47 | 0.170 |
Why?
|
| Stilbenes | 2 | 2015 | 25 | 0.160 |
Why?
|
| Protein Kinases | 3 | 2003 | 28 | 0.160 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 59 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 2 | 2015 | 22 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 100 | 0.160 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2017 | 1 | 0.160 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 67 | 0.150 |
Why?
|
| T-Lymphocytes | 3 | 2017 | 116 | 0.150 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 67 | 0.150 |
Why?
|
| Vasculitis | 1 | 2017 | 23 | 0.150 |
Why?
|
| Air Pollution | 1 | 2016 | 17 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 142 | 0.150 |
Why?
|
| Atherosclerosis | 3 | 2017 | 698 | 0.150 |
Why?
|
| Gene Expression | 2 | 2015 | 332 | 0.140 |
Why?
|
| E-Selectin | 2 | 2017 | 20 | 0.140 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2014 | 90 | 0.140 |
Why?
|
| Adoptive Transfer | 2 | 2012 | 16 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 109 | 0.130 |
Why?
|
| Antigens, CD34 | 2 | 2012 | 54 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 21 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 159 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 320 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2014 | 15 | 0.130 |
Why?
|
| Carbazoles | 1 | 2014 | 6 | 0.130 |
Why?
|
| Intestine, Small | 1 | 2014 | 34 | 0.120 |
Why?
|
| Complement C5a | 1 | 2014 | 2 | 0.120 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2014 | 2 | 0.120 |
Why?
|
| Thrombin | 1 | 2014 | 15 | 0.120 |
Why?
|
| Hirudins | 1 | 2014 | 19 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 138 | 0.120 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 64 | 0.120 |
Why?
|
| Aged | 7 | 2017 | 9510 | 0.120 |
Why?
|
| Cholesterol | 1 | 2015 | 229 | 0.120 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 114 | 0.120 |
Why?
|
| Cytosol | 1 | 2013 | 25 | 0.120 |
Why?
|
| Female | 10 | 2017 | 18236 | 0.120 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2013 | 29 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2014 | 179 | 0.110 |
Why?
|
| Mice, Obese | 3 | 2019 | 22 | 0.110 |
Why?
|
| Teichoic Acids | 2 | 2003 | 7 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2015 | 50 | 0.110 |
Why?
|
| Immunosuppression | 3 | 2019 | 80 | 0.110 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2012 | 3 | 0.110 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2002 | 4 | 0.110 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2012 | 12 | 0.110 |
Why?
|
| 3' Untranslated Regions | 2 | 2010 | 25 | 0.110 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 42 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 22 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 28 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 51 | 0.110 |
Why?
|
| Radioimmunodetection | 1 | 2011 | 3 | 0.100 |
Why?
|
| Fluorescence | 1 | 2011 | 21 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 65 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2008 | 4 | 0.100 |
Why?
|
| Microscopy | 1 | 2011 | 27 | 0.100 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 9 | 0.100 |
Why?
|
| Video Recording | 1 | 2011 | 52 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2012 | 131 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 21 | 0.100 |
Why?
|
| Middle Aged | 6 | 2017 | 10868 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 95 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2011 | 10 | 0.100 |
Why?
|
| Leukocyte Rolling | 1 | 2010 | 3 | 0.100 |
Why?
|
| Microscopy, Video | 1 | 2010 | 7 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 248 | 0.100 |
Why?
|
| P-Selectin | 1 | 2010 | 10 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3108 | 0.100 |
Why?
|
| Renilla | 1 | 2010 | 1 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2016 | 3726 | 0.090 |
Why?
|
| Luciferases | 1 | 2010 | 27 | 0.090 |
Why?
|
| Drug Tolerance | 1 | 2010 | 36 | 0.090 |
Why?
|
| Response Elements | 1 | 2009 | 16 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 203 | 0.090 |
Why?
|
| Lysine | 1 | 2009 | 24 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 681 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2016 | 37 | 0.090 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 51 | 0.090 |
Why?
|
| Methylation | 1 | 2009 | 5 | 0.090 |
Why?
|
| Antigens, Ly | 2 | 2019 | 6 | 0.090 |
Why?
|
| Genotype | 2 | 2007 | 735 | 0.090 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 3 | 2003 | 14 | 0.080 |
Why?
|
| Rats | 3 | 2007 | 1604 | 0.080 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 10 | 0.080 |
Why?
|
| DNA | 1 | 2008 | 204 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 1382 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2006 | 53 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 836 | 0.070 |
Why?
|
| Toll-Like Receptors | 2 | 2003 | 22 | 0.070 |
Why?
|
| Neuritis | 1 | 2005 | 4 | 0.070 |
Why?
|
| Dendritic Cells | 2 | 2017 | 61 | 0.070 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2005 | 32 | 0.070 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2005 | 41 | 0.070 |
Why?
|
| Clonidine | 1 | 2005 | 60 | 0.070 |
Why?
|
| Cecum | 2 | 2015 | 9 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 36 | 0.060 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 5 | 0.060 |
Why?
|
| Pain | 1 | 2005 | 282 | 0.060 |
Why?
|
| Leukocyte Count | 2 | 2017 | 55 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2017 | 64 | 0.050 |
Why?
|
| Dealkylation | 1 | 2002 | 2 | 0.050 |
Why?
|
| Half-Life | 1 | 2002 | 22 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 26 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2002 | 18 | 0.050 |
Why?
|
| Chromatin | 1 | 2002 | 19 | 0.050 |
Why?
|
| Binding Sites | 2 | 2016 | 125 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 43 | 0.050 |
Why?
|
| Genome, Human | 2 | 2014 | 129 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 162 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 519 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 87 | 0.050 |
Why?
|
| Echocardiography | 1 | 2020 | 141 | 0.040 |
Why?
|
| Chemokines, CXC | 2 | 2011 | 9 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 60 | 0.040 |
Why?
|
| Antibodies | 1 | 2018 | 53 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2003 | 519 | 0.040 |
Why?
|
| Adult | 1 | 2011 | 8466 | 0.040 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2018 | 44 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2017 | 67 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2017 | 17 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2017 | 49 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2016 | 5 | 0.040 |
Why?
|
| Air Pollutants | 1 | 2016 | 20 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2017 | 172 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2016 | 30 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2016 | 10 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 17 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2017 | 118 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 1079 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2016 | 100 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2015 | 19 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 34 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ribonucleotide Reductases | 1 | 2015 | 6 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2016 | 350 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2015 | 26 | 0.030 |
Why?
|
| Haplotypes | 2 | 2007 | 220 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 45 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 573 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 172 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 53 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 66 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 795 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 10 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2013 | 7 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 18 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 23 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 74 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 43 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2012 | 9 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 3 | 0.030 |
Why?
|
| Arginase | 1 | 2012 | 8 | 0.030 |
Why?
|
| Weight Loss | 1 | 2015 | 414 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 1131 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 158 | 0.030 |
Why?
|
| Peritonitis | 1 | 2011 | 10 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 2012 | 36 | 0.030 |
Why?
|
| Peritoneum | 1 | 2011 | 24 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 2011 | 19 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 83 | 0.030 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2011 | 4 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2012 | 116 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 543 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 211 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1694 | 0.020 |
Why?
|
| Hispanic Americans | 1 | 2016 | 904 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2012 | 467 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2012 | 449 | 0.020 |
Why?
|
| United States | 1 | 2016 | 3648 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2007 | 7 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 494 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 23 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 192 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 155 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 53 | 0.020 |
Why?
|
| Alleles | 1 | 2007 | 251 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2006 | 5 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2006 | 5 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 2003 | 0.020 |
Why?
|
| Zymosan | 1 | 2005 | 5 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2005 | 84 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2005 | 39 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2005 | 22 | 0.020 |
Why?
|
| Hyperalgesia | 1 | 2005 | 88 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 747 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2003 | 225 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 240 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 7 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 9 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 350 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2002 | 8 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 36 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 73 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 126 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2002 | 37 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 63 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 97 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 422 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 3547 | 0.010 |
Why?
|